X-120442650-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_002294.3(LAMP2):c.877C>A(p.Arg293Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000398 in 1,204,882 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 26 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 3 hem., cov: 22)
Exomes 𝑓: 0.000041 ( 0 hom. 23 hem. )
Consequence
LAMP2
NM_002294.3 synonymous
NM_002294.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.87
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant X-120442650-G-T is Benign according to our data. Variant chrX-120442650-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 507194.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.877C>A | p.Arg293Arg | synonymous_variant | 7/9 | ENST00000200639.9 | NP_002285.1 | |
LAMP2 | NM_001122606.1 | c.877C>A | p.Arg293Arg | synonymous_variant | 7/9 | NP_001116078.1 | ||
LAMP2 | NM_013995.2 | c.877C>A | p.Arg293Arg | synonymous_variant | 7/9 | NP_054701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.877C>A | p.Arg293Arg | synonymous_variant | 7/9 | 1 | NM_002294.3 | ENSP00000200639.4 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111629Hom.: 0 Cov.: 22 AF XY: 0.0000886 AC XY: 3AN XY: 33861
GnomAD3 genomes
AF:
AC:
3
AN:
111629
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33861
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000983 AC: 18AN: 183087Hom.: 0 AF XY: 0.000148 AC XY: 10AN XY: 67589
GnomAD3 exomes
AF:
AC:
18
AN:
183087
Hom.:
AF XY:
AC XY:
10
AN XY:
67589
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000412 AC: 45AN: 1093253Hom.: 0 Cov.: 29 AF XY: 0.0000641 AC XY: 23AN XY: 358769
GnomAD4 exome
AF:
AC:
45
AN:
1093253
Hom.:
Cov.:
29
AF XY:
AC XY:
23
AN XY:
358769
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111629Hom.: 0 Cov.: 22 AF XY: 0.0000886 AC XY: 3AN XY: 33861
GnomAD4 genome
AF:
AC:
3
AN:
111629
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
33861
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Danon disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 26, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at